Journal
CHEMMEDCHEM
Volume 1, Issue 12, Pages 1331-+Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.200600112
Keywords
-
Categories
Funding
- NCI NIH HHS [CA109265] Funding Source: Medline
- NIGMS NIH HHS [P50 GM069663] Funding Source: Medline
Ask authors/readers for more resources
Heat shock protein 90 (Hsp90) has emerged as a promising target for the treatment of cancer, Alzheimer's and Parkinson's diseases, motor impairments, multiple sclerosis, and other disorders. Progress toward the development of both N and C-terminal inhibitors is described.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
